The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics
Friederike Eilts, Sarah Bauer, Keith Fraser, Jonathan S. Dordick, Michael W. Wolff, Robert J. Linhardt, Fuming Zhang
Topics & Concepts
Heparan sulfateSulfationGlycosaminoglycanAngiotensin-converting enzyme 2CoronavirusReceptorHeparinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)PandemicChemistryBiologyImmunologyMicrobiologyMedicineBiochemistryDiseaseInfectious disease (medical specialty)Internal medicineCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and Thrombosis